Cargando…

Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction

Heart failure (HF) is classified according to the degree of reduction in left ventricular ejection fraction (EF) in HF with reduced, mildly reduced, and preserved EF. Biomarkers could behave differently depending on EF type. Here, we analyze the soluble form of the AXL receptor tyrosine kinase (sAXL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cristóbal, Helena, Enjuanes, Cristina, Batlle, Montserrat, Tajes, Marta, Campos, Begoña, Francesch, Josep, Moliner, Pedro, Farrero, Marta, Andrea, Rut, Ortiz-Pérez, José Tomás, Morales, Albert, Sabaté, Manel, Comin-Colet, Josep, García de Frutos, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056687/ https://www.ncbi.nlm.nih.gov/pubmed/36983628 http://dx.doi.org/10.3390/jpm13030446

Ejemplares similares

Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction
por: Alcaide-Aldeano, Alex, et al.
Publicado: (2020)

Blood Differential Gene Expression in Patients with Chronic Heart Failure and Systemic Iron Deficiency: Pathways Involved in Pathophysiology and Impact on Clinical Outcomes
por: Díez-López, Carles, et al.
Publicado: (2021)

Use of potassium-binder patiromer for up-titration of renin–angiotensin–aldosterone system inhibition therapy in a patient with chronic heart failure and reduced ejection fraction followed in a multidisciplinary integrated chronic care management programme: a case report
por: Jiménez-Marrero, Santiago, et al.
Publicado: (2020)

Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients
por: Ras-Jiménez, Maria del Mar, et al.
Publicado: (2023)

Association Between Norepinephrine Levels and Abnormal Iron Status in Patients With Chronic Heart Failure: Is Iron Deficiency More Than a Comorbidity?
por: Moliner, Pedro, et al.
Publicado: (2019)

Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain)
por: Farré, Nuria, et al.
Publicado: (2017)

Data on clinical characteristics of a heart failure patients’ cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP()
por: Batlle, M., et al.
Publicado: (2016)

Defining quantification methods and optimizing protocols for microarray hybridization of circulating microRNAs
por: Garcia-Elias, Anna, et al.
Publicado: (2017)

Axl expression is increased in early stages of left ventricular remodeling in an animal model with pressure-overload
por: Batlle, Montserrat, et al.
Publicado: (2019)

Atrial Fibrillation in Heart Failure Is Associated with High Levels of Circulating microRNA-199a-5p and 22–5p and a Defective Regulation of Intracellular Calcium and Cell-to-Cell Communication
por: Garcia-Elias, Anna, et al.
Publicado: (2021)

Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study
por: González-Costello, José, et al.
Publicado: (2018)

Breaking the 30-day barrier: Long-term effectiveness of a nurse-led 7-step transitional intervention program in heart failure
por: Alcoberro, Lidia, et al.
Publicado: (2023)

Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients
por: Farré, Núria, et al.
Publicado: (2017)

Gender Differences in Health-Related Quality of Life in Patients with Systolic Heart Failure: Results of the VIDA Multicenter Study
por: Garay, Alberto, et al.
Publicado: (2020)

Real-World Epidemiology of Potassium Derangements Among Chronic Cardiovascular, Metabolic and Renal Conditions: A Population-Based Analysis
por: Jiménez-Marrero, Santiago, et al.
Publicado: (2020)

Prognostic Value of the Acute-to-Chronic Glycemic Ratio at Admission in Heart Failure: A Prospective Study
por: Carrera, Mª José, et al.
Publicado: (2021)

High-Sensitivity Troponin T and Soluble Form of AXL as Long-Term Prognostic Biomarkers after Heart Transplantation
por: Mirabet, Sonia, et al.
Publicado: (2018)

Psychosocial factors partially explain gender differences in health‐related quality of life in heart failure patients
por: Tapia, Javier, et al.
Publicado: (2022)

Soluble AXL as a marker of disease progression and survival in melanoma
por: Flem-Karlsen, Karine, et al.
Publicado: (2020)

Systematic review and meta‐analysis of intravenous iron‐carbohydrate complexes in HFrEF patients with iron deficiency
por: Sindone, Andrew, et al.
Publicado: (2022)

Quality of life and disease experience in patients with heart failure with reduced ejection fraction in Spain: a mixed-methods study
por: Rubio, Raül, et al.
Publicado: (2021)

Iron deficiency in chronic heart failure: case‐based practical guidance
por: Lam, Carolyn S. P., et al.
Publicado: (2018)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Neurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells
por: Tajes, M., et al.
Publicado: (2021)

Síndrome de tako-tsubo asociado con COVID-19
por: Oyarzabal, Loreto, et al.
Publicado: (2020)

Tako-tsubo syndrome associated with COVID-19
por: Oyarzabal, Loreto, et al.
Publicado: (2020)

Tratamiento neurohormonal en miocardiopatía de tako-tsubo precipitada por COVID-19. Respuesta
por: Oyarzabal, Loreto, et al.
Publicado: (2021)

Neurohormonal treatment in tako-tsubo cardiomyopathy precipitated by COVID-19. Response
por: Oyarzabal, Loreto, et al.
Publicado: (2021)

Study design of Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS)
por: Yun, Sergi, et al.
Publicado: (2020)

Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat
por: González-Juanatey, José Ramón, et al.
Publicado: (2023)

Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis
por: Martínez-Bosch, Neus, et al.
Publicado: (2021)

Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status
por: Comín-Colet, Josep, et al.
Publicado: (2013)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
por: Gomez‐Lara, Josep, et al.
Publicado: (2021)

Conservative management of aortic root rupture complicated with cardiac tamponade following transcatheter aortic valve implantation
por: Vannini, Luca, et al.
Publicado: (2017)

Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy
por: Díez-López, Carles, et al.
Publicado: (2022)

Patient risk factors for developing a drug-related problem in a cardiology ward
por: Urbina, Olatz, et al.
Publicado: (2014)

Atrial fibrosis in a chronic murine model of obstructive sleep apnea: mechanisms and prevention by mesenchymal stem cells
por: Ramos, Pablo, et al.
Publicado: (2014)

A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target
por: Tutusaus, Anna, et al.
Publicado: (2019)

Ischemic aetiology, self-reported frailty, and gender with respect to cognitive impairment in chronic heart failure patients
por: González-Moneo, María J, et al.
Publicado: (2016)

Clinical practices and attitudes regarding the diagnosis and management of heart failure: findings from the CORE Needs Assessment Survey
por: Howlett, Jonathan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tn44keh1s8dkte593h8usq345e